Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 1, 2001, Pages 66-71

  Arslanian, Silva A ^a   Lewy, Vered D ^a   Danadian, Kapriel ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LIPID STORAGE; LIVER; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 0035143773     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.1.66     Document Type: Article

References (33)

1. Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women
2. Insulin resistance and the polycystic ovary syndrome. Mechanism and implications for pathogenesis
3. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome. A prospective, controlled study in 254 affected women
4. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
5. The polycystic ovary syndrome
6. Endocrinological ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients. A comparative study
7. Early metabolic abnormalities in adolescents girls with PCOS
8. Definition: Clinical manifestations and prevalence of PCOS
9. Differences in the in vivo insulin secretion and sensitivity in healthy black vs white adolescents
10. Insulin sensitivity in African-American children with and without family history of type 2 diabetes
11. Dippers and non-dippers
12. Ambulatory blood pressure monitoring: Coming of age in nephrology
13. Development of normative ambulatory blood pressure data in children
14. Correlations between fatty acid and glucose metabolism: Potential explanation of insulin resistance of puberty
15. Prior to use of estrogen replacement therapy are users healthier than nonusers
16. Glucose-fatty acid interactions in prepubertal and pubertal children: Effects of lipid infusion
17. Testosterone treatment in adolescents with delayed puberty: Changes in body composition, protein, fat, and glucose metabolism
18. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function
19. Type 2 diabetes in children and adolescents
20. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem
21. Defects in β-cell function in functional ovarian hyperandrogenism
22. β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
23. Insulin secretory defects in polycystic ovary syndrome
24. Cardiovascular consequences of polycystic ovary syndrome
25. Coronary heart disease risk factors in women with polycystic ovary syndrome
26. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women
27. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
28. Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance
29. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
30. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: Relation to anthropometric, endocrine and metabolic variables
31. Noninvasive ambulatory 24h blood pressures and basal blood pressures predict the development of sustained hypertension from a borderline state
32. Ambulatory blood pressure monitoring and hypertensive target-organ damage in children
33. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience